Breast Cancer Non-Sponsored Content

Breast Cancer Non-Sponsored

Madison Johnson, BSHER2 Breast Cancer | July 3, 2025

Top research highlights from ESMO Breast Cancer 2025 showcase advances in treatment and care for patients with breast cancer.

David M. Waterhouse, MD, MPHBreast Cancer News | July 2, 2025

Dr. David Waterhouse shares how clinical trials can be decentralized to better serve patients in community settings.

Lauren Dembeck, PhDBreast Cancer News | June 27, 2025

FDA authorizes CLAIRITY BREAST, the first AI tool to predict 5-year breast cancer risk from screening mammograms.

Debra Patt, MD, PhD, MBABreast Cancer News | June 24, 2025

OncoPRO is advancing ePRO use in oncology through integration tips, EOM alignment, and improved patient outcomes.

Alexa StecklerBreast Cancer News | June 23, 2025

ASCO 2025 study reveals gaps in fertility counseling and awareness among patients with cancer who are of reproductive age.

Rebecca Shatsky, MDHR Breast Cancer | June 18, 2025

New drugs like vepdegestrant and oral SERDs may reshape HR+ breast cancer treatment with novel mechanisms and CDK4/6 combos.

David M. Waterhouse, MD, MPHTriple-Negative Breast Cancer | June 17, 2025

Dr. David Waterhouse discusses geographic barriers to TNBC trials for Black women and the case for decentralized research.

Hatem Soliman, MDTriple-Negative Breast Cancer | June 12, 2025

TVEC plus chemo shows promise in early TNBC, boosting immune response and survival with favorable safety profile.

Debra Patt, MD, PhD, MBABreast Cancer News | June 12, 2025

Dr. Patt discusses how AI is transforming oncology care, and how to implement it responsibly and effectively.

Sarah Sammons, MDHR Breast Cancer | June 12, 2025

Dr. Sammons on RLY-2608 plus fulvestrant in HR+/HER2– mBC with PIK3CA mutations: safety, efficacy, and trial updates.